Search for: "ASTRAZENECA LP"
Results 61 - 80
of 138
Sort by Relevance
|
Sort by Date
3 Jan 2012, 10:20 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011). [read post]
29 Dec 2011, 6:53 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011). [read post]
15 Dec 2011, 10:17 am
AstraZeneca Pharmaceuticals LP, No. 3:11-cv-04001-JAP-TJB, slip op. [read post]
11 Dec 2011, 9:00 pm
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
11 Dec 2011, 9:00 pm
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
7 Dec 2011, 9:59 pm
AstraZeneca Pharma. [read post]
CAFC Rules “Secret Prior Art” Requires Only Appreciation that Invention Made in Teva Pharmaceutical*
4 Dec 2011, 8:46 am
AstraZeneca Pharmaceuticals LP to surprise, and unpleasantly upend the patentee. [read post]
1 Dec 2011, 9:22 pm
LP, No. 2011-1091 (Fed. [read post]
1 Dec 2011, 7:40 pm
Astrazeneca Pharamceuticals LP (Fed. [read post]
18 Oct 2011, 9:33 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011)? [read post]
27 Sep 2011, 12:38 pm
McDermott Will & Emery has added two lawyers to its life sciences practice in Washington, including the top in-house counsel for AstraZeneca Pharmaceuticals LP, the firm announced Monday. [read post]
7 Aug 2011, 8:36 pm
Hetero Drugs, Ltd., Unit III et al. 3:11-cv-04468; filed August 2, 2011 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
29 Jun 2011, 8:53 am
Astrazeneca LP v. [read post]
11 Mar 2011, 11:46 am
AstraZeneca Pharmaceuticals LP, 2011 WL 833222, slip op. (11th Cir. [read post]
15 Feb 2011, 4:06 am
AstraZeneca LP, 605 F.Supp.2d 669, 678-79 (W.D.Pa.2009) (discussing why the “professional paradigm” places the physician as the relevant decision maker in the health services industry), aff’d on other grounds, 372 Fed. [read post]
2 Feb 2011, 2:39 pm
AstraZeneca LP v. [read post]
26 Jan 2011, 1:31 am
In April of last year, we obtained a $520 million settlement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to resolve allegations that marketing of the anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA caused false claims to be submitted to federal health care programs. [read post]
29 Dec 2010, 12:54 pm
We hope all our readers had excellent holidays, didn’t get stranded in the snow (here on the US East Coast), and received lots of desired presents due to what the economic stats we’ve seen are saying has been a better than expected retailing season. [read post]
1 Dec 2010, 12:15 am
Navinta LLC (Property, intangible) Pulmicort Respules (Budesonide) – US: Liability for future indirect infringement: AstraZeneca LP v. [read post]
23 Nov 2010, 1:00 am
By Jason Rantanen In an earlier post, I summarized the Federal Circuit's affirmance of a preliminary injunction prohibiting Apotex from marketing its generic version of AstraZeneca's budesonide in AstraZeneca LP v. [read post]
